Related Experiment Videos
Delusional parasitosis: a clinical profile.
M S Bhatia1, T Jagawat, S Choudhary
1University College of Medical Sciences, Delhi, India.
International Journal of Psychiatry in Medicine
|July 20, 2000
Summary
Delusional parasitosis, a psychiatric disorder, often has a prolonged onset. Pharmacotherapy achieved complete remission in 54% of patients, highlighting treatment efficacy for this condition.
Area of Science:
- Psychiatry
- Dermatology
Background:
- Delusional parasitosis is a monohypochondriacal psychosis.
- Its prognosis and treatment outcomes are not well-established.
Purpose of the Study:
- To report on the treatment and outcomes of 52 consecutive delusional parasitosis cases.
- To provide insights into the management of this psychiatric disorder.
Main Methods:
- A retrospective case series of 52 patients diagnosed with delusional parasitosis.
- Pharmacotherapy, including pimozide, amitriptyline, and fluoxetine, was administered.
Main Results:
- Most cases (92%) had an insidious onset with symptoms lasting over six months.
- Complete remission was observed in 54% of patients receiving pharmacotherapy.
- Comorbidities included diabetes mellitus, leprosy, dementia, depression, and trichotillomania.
Conclusions:
- Pharmacotherapy demonstrates significant efficacy in treating delusional parasitosis.
- Further research is needed to fully understand the treatment and prognosis of this disorder.